Sign in / Join Now
ETFs & Funds
Second is $
Neurocrine Biosciences. Small bio-tech, consistent revenue over last 5 quarters, needs a closer look though.
Add a reply...
Latest StockTalks »
people get NBIX breaking news and analysis by email alert.
Get email alerts on NBIX »
Neurocrine Biosciences, Inc.
Get latest price
From other sites
Neurocrine Biosciences Announces Conference Call And Webcast To Report Third Quarter 2016 Results
at TheStreet (Wed, 1:00PM)
Neurocrine Biosciences Breaks Below 200-Day Moving Average - Notable for NBIX
at Nasdaq.com (Oct 11, 2016)
Neurocrine Announces INGREZZA™ (valbenazine) New Drug Application For The Treatment Of Tardive Dyskinesia Has Been Accepted For Priority Review By U.S. FDA
at TheStreet (Oct 11, 2016)
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
at TheStreet (Sep 7, 2016)
Neurocrine Biosciences To Present At The Baird 2016 Healthcare Conference
at TheStreet (Sep 1, 2016)